focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Ormonde Mining acquires stake in Peak Nickel

Tue, 07th Feb 2023 19:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Haydale Graphene Industries PLC - Ammanford, Wales-based graphene technology company - Says that its "bespoke" mechanical graphene is used to create kayaks for Norse Kayaks. Adds that the Norse kayak is 30% lighter to 16 kilogrammes from 23kg. "The use of graphene has exceeded our expectations and we are sure that this will set a new standard of what is possible to do with a sea kayak. We have never seen this kind of impact strength on light weight sea kayaks in our 20 years' experience in the kayaking business," Norse founder Kjetil Sandvik says.

----------

Tekcapital PLC - London-based intellectual property investor - Launches its Lucyd Lyte 2.0 eyewear. Intends to introduce the product to optical and speciality retail chains worldwide. Notes that it is a "major upgrade" to its flagship Lucyd Lyte audio eyewear platform.

----------

Witan Investment Trust PLC - investment firm - Declares a fourth interim dividend of 1.60p per ordinary share, taking it total dividends for 2022 to 5.80p. Intend to grow its dividend "in real terms," ahead of inflation. Notes that its dividends have grown "substantially" ahead of UK inflation over the past 5 and 10 years.

----------

Ormonde Mining PLC - cash shell, former Dublin-based mineral resource company - Is temporarily suspended from trading on AIM on Wednesday, "pending an announcement and publication of an admission document." Explains that it became a cash shell in October 2022 and was therefore required to announce an acquisition or acquisitions that would be a reverse takeover. Says that it acquired a 20% stake in Peak Nickel Ltd for GBP450,000. Adds that it was granted an option to invest a further GBP4 million in cash in PNL, taking its stake to 49.9% and to buy the remaining 80% of PLN through the issue of Ormonde ordinary shares. Notes that this option can be exercised following the completion of the initial work programme. Notes that the exercise will be dependent on the results of the work programme, among other things, but satisfy the AIM Rule 14 conditions in relation to being a cash shell.

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Files four new patent applications to protect "innovations" around novel gene targets, associated disease-relevant biology and proprietary siRNA stabilisation chemistries. siRNA is short for small interfering RNA. Notes that the new applications build on a period of IP generation in 2022, where a series of patent applications were filed to protect 13 inventions. "This latest announcement of patent filings reflects our continued pace of innovation and progress towards an in-house pipeline of first-in-class RNAi candidates derived from our computational platform. We will continue to build on this progress, maintain the momentum of invention and actively protect our expanding intellectual property portfolio," CEO Ali Mortazavi comments.

----------

Lok'n Store Group PLC - Hampshire, England-based self-storage - Says that its board approved a transition for its shares on AIM to the Stock Exchange Electronic Trading System platform from the London Stock Exchange's Stock Exchange Electronic Trading Service. The move was effective from February 7. Explains that the move is supposed to provide investors with access to the entire SETS system, "providing liquidity via traditional order book trades, as well as firm two-way quotes from market makers."

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
16 Oct 2013 11:57

UK WINNERS & LOSERS: Hargreaves Continues To Rise, e-Therapeutics Trips

Read more
16 Oct 2013 08:56

e-Therapeutics Pretax Loss Widens As R&D Expenditure Rises

Read more
30 Sep 2013 18:45

DIRECTOR DEALINGS: E-Therapeutics Exec, Wife Combined Shares Total 1.8M

Read more
24 Jul 2013 15:53

Wife of DS Smith CEO sells 5.6m-pound stake

The wife of DS Smith frontman Miles Roberts sold a substantial sum of shares in the packaging and office supplies firm on the same day it was revealed the Chief Executive Officer (CEO) received a big pay increase last year. The move came on Tuesday, the same day DS Smith released its annual report

Read more
14 May 2013 09:46

e-Therapeutics pleases with pipeline progress

News from biotech company e-Therapeutics about the progress of two clinical trials for its cancer drug pleased the markets on Tuesday. The AIM-listed company provided first findings for the company's ETS2101 drug candidate in Phase I trials in the US for patients with brain cancer and in the UK fo

Read more
14 May 2013 08:04

Tuesday broker round-up UPDATE

Babcock International: Jefferies increases target price from 1080p to 1250p and maintains a buy recommendation. Barratt Developments: Bank of America takes target price from 265p to 325p, while downgrading to neutral. Belgravium Technologies: WH Ireland places both its target price and its neutral

Read more
10 May 2013 07:14

Friday broker round-up UPDATE

Afren: Westhouse Securities initiates with a target price of 160p and a buy recommendation. Ashmore Group: Credit Suisse raises target price from 375p to 440p upgrading from underperform to neutral. Barratt Developments: Citigroup increases target price from 245p to 315p leaving its neutral rating

Read more
19 Feb 2013 16:21

Debenhams Executive Director adds to stake

Michael Sharp, the Executive Director of retail chain Debenhams, has topped up his stake in the group with the purchase of 50,000 shares. Sharp, who has been in his current role since September 2011, bought the shares at 97.20p for a total of £48,598. He now holds 6.2m shares in the company. Debe

Read more
11 Feb 2013 09:15

e-Therapeutics shares jump following 40m equity issue

Drug discovery and development company e-Therapeutics is proposing to raise 40m pounds through an issue of new ordinary shares to existing and new institutional investors. The new shares will be priced at 32p, a premium of 4.0% to the closing mid-market price on Friday. Following the proposed issu

Read more
23 Oct 2012 09:23

Tuesday broker round-up

Aggreko: UBS cuts target from 2,750p to 2,550p, buy rating kept. ARM Holdings: Investec keeps buy rating and 800p target. Avacta: Panmure Gordon keeps buy rating and 1.75p target. AZ Electronic: Canaccord Genuity ups target from 360p to 376p, buy rating kept. Babcock: JPMorgan Cazenove ups targe

Read more
22 Oct 2012 08:19

Monday broker round-up - UPDATE

888 Holdings: Morgan Stanley ups target from 125p to 130p, overweight rating kept. Aggreko: Jefferies cuts target from 2,800p to 2,535p, buy rating kept; HSBC downgrades to underweight, target cut from 2,350p to 1,750p; JPMorgan Cazenove cuts target from 2,360p to 2,165p, neutral rating kept; Barcl

Read more
22 Oct 2012 07:53

e-therapeutics produces mixed interims

e-therapeutics, a drug discovery and development company, produced mixed interims with slightly increased losses, but reported progress on its lead cancer drug. As expected, first half losses increased to £1.8m (2011: loss of £1.5m), reflecting increased investment in the business. The company ha

Read more
15 Mar 2011 17:05

Bramson vehicle buys more shares in F&C

F&C Asset Management chairman Edward Bramson's investment vehicle SIGA LP has acquired more shares in the asset management company. Bramson was appointed chairman of F&C last month after a shareholder coup removed the previous incumbent, along with another non-executive, and appointed three new di

Read more
14 Mar 2011 17:19

Wife of outgoing FD sells British Land shares

Diane Roberts, the wife of British Land finance director Graham Roberts, has raised more than £1m by selling more than three-quarters of the couple's stake in the property investor. She sold 191,780 shares at 562.8p each, which raised £1.08m. The couple are left with 50,464 shares in British Land.

Read more
4 Mar 2011 17:03

Shaftesbury boss invests £100,000

Shaftesbury chief executive Jonathan Lane has invested a further £100,000 in the property investor. Lane has bought 22,222 shares at 450p each. That takes his stake to 966,233 shares, which is worth £4.3m at the latest purchase price. Lane raised just over £99,000 from the sale of option shares la

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.